Clinical trial
A Prospective, Multicentric Clinical Proof-of-concept Study to Stratify Targeted Therapies Adapted to Molecular Profiling of Relapsed or Refractory Pediatric Tumors
NCT02613962 is registered in ClinicalTrials.gov with Gustave Roussy, Cancer Campus, Grand Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicentric Clinical Proof-of-concept Study to Stratify Targeted Therapies Adapted to Molecular Profiling of Relapsed or Refractory Pediatric Tumors
- Lead sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 13, 2016
- Completion date
- November 16, 2022
- Enrollment
- 791 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
relapsed or refractory pediatric tumor